Publications

5808 Results

Relationship between metformin use and recurrence and survival in patients with resected stage III colon cancer receiving adjuvant chemotherapy: results from North Central Cancer Treatment Group N0147 (Alliance)

Authors
P Singh;Q Shi;N Foster;A Grothey;S Nair;E Chane;A Shields;R Goldberg;S Gill;M Kahlenberg;F Sinicrope;D Sargent;S Alberts
Journal / Conference
Oncologist Dec;21(12):1509-1521; Epub 2016 Nov 23
Year
2016
Research Committee(s)
Gastrointestinal
PMID
PMID27881709
PMC
PMC5153338
Study Number(s)
CTSU/N0147

Adverse health effects of intermittent vs continuous androgen deprivation therapy for metastatic prostate cancer - Reply

Authors
D Hershman;J Unger
Journal / Conference
JAMA Oncology May 1;2(5):686-687
Year
2016
Research Committee(s)
Genitourinary
PMID
PMID27244679
Study Number(s)
SWOG-9346

Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia

Authors
Gu Z;M Churchman;K Roberts;Y Li;R Harvey;K McCastlain;S Reshmi;D Payne-Turner;I Iacobucci;Y Shao;IM Chen;M Valentine;D Pei;K Mungall;A Mungall;Y Ma;R Moore;M Marra;E Stonerock;J Gastier-Foster;M Devidas;Y Dai;B Wood;M Borowitz;E Larsen;K Maloney;L Mattano;A Angiolillo;W Salzer;M Burke;F Gianni;O Spinnelli;JP Radich;MD Minden;A Moorman;B Patel;A Fielding;J Rowe;S Luger;R Bhatia;I Aldoss;SJ Forman;J Kohlschmidt;K Mrozek;G Marcucci;C Bloomfield;W Stock;W Kornblau;H Kantarjian;M Konopleva;E Paietta;C Willman;M Loh;S Hunger;C Mullighan
Journal / Conference
Nature Communications Nov 8;7:13331
Year
2016
Research Committee(s)
Leukemia
PMID
PMID27824051
PMC
PMC5105166
Study Number(s)
S0333, SWOG-9400, S9910

S0502: A SWOG phase III randomized study of imatinib, with or without bevacizumab, in patients with untreated metastatic or unresectable gastrointestinal stromal tumors

Authors
CD Blanke;C Rankin;C Corless;J Eary;P Okuno;S George;M Heinrich
Journal / Conference
The Oncologist Dec;20(12):1353-1354
Year
2015
Research Committee(s)
Gastrointestinal
PMID
PMID26576593
PMC
PMC4679092
Study Number(s)
S0502

SWOG S0221: A phase III trial comparing chemotherapy schedules in high-risk early breast cancer

Authors
GT Budd;W Barlow;HCF Moore;T Hobday;JA Stewart;C Isaacs;M Salim;J Cho;K Rinn;K Albain;H Chew;GV Burton;TD Moore;G Srkalovic;BA McGregor;LE Flaherty;RB Livingston;DL Lew;JR Gralow;GN Hortobagyi
Journal / Conference
Journal of Clinical Oncology 33(1):58-64
Year
2015
Research Committee(s)
Breast
PMID
PMID25422488
PMC
PMC4268253
Study Number(s)
S0221

Pharmacogenetic analysis of INT 0144 trial: association of polymorphisms with survival and toxicity in rectal cancer patients treated with 5-FU and radiation

Authors
P Bohanes;C Rankin;H Lenz;T Winder;C Ulrich;S Smalley;K Danenberg;K Makar;W Zhang;J Benedetti;C Blanke
Journal / Conference
Clinical Cancer Research Apr 1;21(7):1583-1590
Year
2015
Research Committee(s)
Gastrointestinal
PMID
PMID25589620
PMC
PMC4566931
Study Number(s)
SWOG-9304 (INT-0144)

A phase III study of radiation therapy (RT) and O6-benzylguanine, (O6BG) plus BCNU versus RT and BCNU alone and methylation status in newly diagnosed GBM and gliosarcoma: SWOG study S0001

Authors
D Blumenthal;C Rankin;K Stelzer;A Spence;A Sloan;D Moore;K Yost;S Schulman;E Rushing
Journal / Conference
International Journal of Clinical Oncology Aug;20(4):650-658
Year
2015
Research Committee(s)
Brain
PMID
PMID25407559
PMC
PMC4465052
Study Number(s)
S0001

Ibritumomab Consolidation After 3 Cycles of CHOP Plus Radiotherapy in High-Risk Limited-Stage Aggressive B-cell Lymphoma: SWOG S0313

Authors
D Persky;TP Miller;J Unger;BD Stea;OW Press;LS Constine;K Barton;JW Friedberg;M Leblanc;RI Fisher
Journal / Conference
Blood Jan 8;125(2):236-241
Year
2015
Research Committee(s)
Lymphoma
PMID
PMID25395425
PMC
PMC4287635
Study Number(s)
S0313

Phase II study of mTOR inhibitor everolimus (RAD001) in advanced malignant pleural mesothelioma (MPM): SWOG S0722

Authors
S-H Ou;J Moon;L Garland;PC Mack;J Testa;A Tsao;A Wozniak;D Gandara
Journal / Conference
Journal of Thoracic Oncology, Feb; 10(2):387-391
Year
2015
Research Committee(s)
Lung
PMID
PMID25611229
PMC
PMC4304604
Study Number(s)
S0722

Prognostic significance of NPM1 mutations in the absence of FLT3-Internal Tandem Duplication in older patients with acute myeloid leukemia: a SWOG and UK National Cancer Research Institute/Medical Research Council report

Authors
F Ostronoff;M Othus;A Burnett;E Estey;FR Appelbaum;A Evans;J Godwin;A Gilkes;K Kopecky;M Lazenby;AF List;M Fang;V Oehler;S Petersdorf;E Pogosova-Agadjanyan;J Radich;C Willman;S Meshinchi;DL Stirewalt
Journal / Conference
Journal of Clinical Oncology, Apr 1;33(10):1157-1164
Year
2015
Research Committee(s)
Leukemia
PMID
PMID25713434
PMC
PMC437285
Study Number(s)
S0106, SWOG-9031, SWOG-9333, SWOG-9500